← Back to Search

Weight Loss Program for Breast Cancer Survivors

N/A
Waitlist Available
Led By Nia S Mitchell, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
African American women diagnosed with breast cancer with BMI ≥ 25 kg/m2 after completion of primary therapy (surgery, radiation, adjuvant or neo-adjuvant chemotherapy)
Be older than 18 years old
Must not have
Those taking a weight loss medication
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve a weight loss program called Take Off Pounds Sensibly (TOPS) for African American breast cancer survivors. The study involves using feedback from focus groups of African American women who

Who is the study for?
This trial is for African American women who have survived breast cancer. It aims to adapt a weight loss program called TOPS to better suit their needs. Participants will review materials and provide feedback to help tailor the program.
What is being tested?
The intervention being tested is the Take Off Pounds Sensibly (TOPS) classes, which are community-led weight loss programs. The study seeks to modify these classes based on feedback from focus groups of African American breast cancer survivors.
What are the potential side effects?
Since this trial involves non-medical interventions like lifestyle changes through weight loss classes, there are no direct medical side effects associated with drugs or surgical procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am an African American woman with breast cancer, a BMI of 25 or higher, and have finished my initial cancer treatments.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently taking medication to lose weight.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percentage of TOPS group session attendance

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: TOPS ClassesExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,463 Previous Clinical Trials
2,981,880 Total Patients Enrolled
24 Trials studying Weight Loss
5,583 Patients Enrolled for Weight Loss
Nia S Mitchell, MDPrincipal InvestigatorDuke University
1 Previous Clinical Trials
115 Total Patients Enrolled
~17 spots leftby Sep 2027